June 6, 2017: Allergan, Inc. of Irvine, CA, obtained U.S. Patent No. 9,669,039, “Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods”.
Biocompatible intraocular implants, such as microparticles, include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the prostamide component may be encapsulated by the polymeric component. The present implants include oil-in-oil emulsified implants or microparticles. Methods of producing the present implants are also described. The implants may be placed in an eye to treat or reduce at least one symptom of an ocular condition, such as glaucoma.
The patent may be viewed at the USPTO website at http://pdfpiw.uspto.gov/.piw?Docid=09669039.